Inadequate treatment of symptomatic cancer

British Journal of Surgery

Volumn 92, Issue 4, 2005, Pages 422-428

  Kingsmore, D B ^a   Hole, D J ^b   Gillis, C R ^b   George, W D ^a,b  

^a WESTERN INFIRMARY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER SIZE; CANCER SURVIVAL; CLINICAL PROTOCOL; CONFIDENCE INTERVAL; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SOCIOECONOMICS; SURGICAL TECHNIQUE; SURVIVAL RATE;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; QUALITY OF HEALTH CARE; RISK FACTORS; SCOTLAND; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 17144394104     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4869     Document Type: Review

References (27)

1. Fentiman IS, Mansel RE. The axilla: not a no-go zone. Lancet 1991; 337: 221-223.
2. Kiricuta CI, Tausch J. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer 1992; 69: 2496-2501.
3. Cabanes PA, Salmon RJ, Vilcoq JR, Durand JC, Fourquet A, Gautier C et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 1992; 339: 1245-1248.
4. O'Higgins N. How do I do it - how I minimize morbidity in axillary dissection. Eur J Surg Oncol 1994; 20: 80-81.
5. Greenall MJ. Current controversies in the surgical management of breast cancer. Ann Oncol 1994; 5: S39-S43.
6. Blichert Toft M. Surgical techniques: full dissection of the axilla vs sampling in the treatment of operable breast cancer. Breast 1995; 4: 217-218.
7. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. N Engl J Med 1995; 333: 1444-1455.
8. Cuzick J, Stewart H, Rutquist L et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994; 12: 447-453.
9. Cuzick J, Stewart H, Peto R, Baum M, Fisher B, Host H et al. Over-view of randomised trials of adjuvant post-operative radiotherapy in breast cancer. Cancer Treat Rep 1987; 71: 15-29.
10. Cuzick J, Stewart H, Peto R, Fisher B, Kaae S, Johansen H, et al. Over-view of randomised trials comparing radical mastectomy against simple mastectomy with radiotherapy in breast cancer. Cancer Treat Rep 1987; 71: 7-14.
11. Stjernswaard J. Can survival be decreased by postoperative irradiation. Int J Rad Oncol Biol Phys 1977; 2: 1171-1175.
12. Levitt SH. Is there a role for post-operative adjuvant radiation in breast cancer? Beautiful hypothesis versus ugly facts: 1987 Gilbert H. Fletcher lecture. Int J Radiat Oncol Biol Phys 1988; 14: 787-796.
13. Fletcher GH, Montague ED. Does adequate irradiation in the internal mammary chain and supraclavicular nodes improve survival rates? Int J Radiat Oncol Biol Phys 1987; 4: 481-492.
14. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000; 355: 1757-1770.
15. Whelan TJ, Julian J, Wright J, Jadad AR, Levine ML. Does locoregional radiotherapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 2000; 18: 1220-1229.
16. Guadagnoli JC, Weeks JC, Shapiro CL, Gurwitz JH, Borbas C, Soumerai SB et al. Use of breast-conserving surgery for treatment of stage I and stage II breast cancer. J Clin Oncol 1998; 16: 101-106.
17. Kotwall CA, Covington DL, Rutledge R, Churchill MP, Meyer AA. Patient, hospital, and surgeon factors associated with breast conservation surgery. A statewide analysis in North Carolina. Ann Surg 1996; 224: 419-429.
18. Sainsbury R, Haward B, Rider L, Johnston C, Round C. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 1995; 345: 1265-1270.
19. Greenfield S, Blanco DM, Elashoff RM, Ganz PA. Patterns of care related to age of breast cancer patients. JAMA 1987; 257: 2766-2770.
20. Carstairs V and Morris R. Deprivation and Health in Scotland. Aberdeen University Press: Aberdeen, 1988.
21. Kings' Fund Forum Consensus Statement. Development conference: treatment of primary breast cancer. BMJ 1986; 293: 946-947.
22. Forrest AP, Stewart HJ, Everington D, Prescott RJ, McArdle CS, Harnett AN et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet 1996; 348: 708-713.
23. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997; 337: 949-955.
24. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337: 956-962.
25. The Breast Surgeons Group of the British Association of Surgical Oncology. Guidelines for Surgeons in the Management of Symptomatic Breast Disease in the United Kingdom. BASO: London, 1995.
26. Goy JCM, Dobbs HJ, Henderson SM, Humphreys S, Michell MJ. Variations in referral patterns for postoperative radiotherapy of patients with screen-detected breast cancer in the South Thames (East) Region. Clin Oncol 1998; 10: 24-29.
27. Winstanley JHR, Leinster SJ, Wake PN, Copeland GP. The value of guidelines in a breast screening service. Eur J Surg Oncol 1995; 21: 140-142.